Taiwan · Delayed Price · Currency is TWD TTY Biopharm Company Statistics
Total Valuation
TPEX:4105 has a market cap or net worth of TWD 19.00 billion. The enterprise value is 18.96 billion.
| Market Cap | 19.00B |
| Enterprise Value | 18.96B |
Important Dates
The next estimated earnings date is Thursday, November 5, 2026.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | Mar 26, 2026 |
Share Statistics
TPEX:4105 has 248.65 million shares outstanding. The number of shares has decreased by -0.02% in one year.
| Current Share Class | 248.65M |
| Shares Outstanding | 248.65M |
| Shares Change (YoY) | -0.02% |
| Shares Change (QoQ) | +0.07% |
| Owned by Insiders (%) | 11.09% |
| Owned by Institutions (%) | 12.41% |
| Float | 192.54M |
Valuation Ratios
The trailing PE ratio is 10.98.
| PE Ratio | 10.98 |
| Forward PE | n/a |
| PS Ratio | 2.85 |
| PB Ratio | 2.45 |
| P/TBV Ratio | 2.98 |
| P/FCF Ratio | 10.34 |
| P/OCF Ratio | 9.67 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.40, with an EV/FCF ratio of 10.32.
| EV / Earnings | 10.94 |
| EV / Sales | 2.85 |
| EV / EBITDA | 8.40 |
| EV / EBIT | 9.21 |
| EV / FCF | 10.32 |
Financial Position
The company has a current ratio of 2.13, with a Debt / Equity ratio of 0.27.
| Current Ratio | 2.13 |
| Quick Ratio | 1.47 |
| Debt / Equity | 0.27 |
| Debt / EBITDA | 1.02 |
| Debt / FCF | 1.15 |
| Interest Coverage | 53.68 |
Financial Efficiency
Return on equity (ROE) is 25.11% and return on invested capital (ROIC) is 24.46%.
| Return on Equity (ROE) | 25.11% |
| Return on Assets (ROA) | 10.35% |
| Return on Invested Capital (ROIC) | 24.46% |
| Return on Capital Employed (ROCE) | 21.14% |
| Weighted Average Cost of Capital (WACC) | 4.52% |
| Revenue Per Employee | 19.46M |
| Profits Per Employee | 5.07M |
| Employee Count | 342 |
| Asset Turnover | 0.59 |
| Inventory Turnover | 2.13 |
Taxes
In the past 12 months, TPEX:4105 has paid 491.00 million in taxes.
| Income Tax | 491.00M |
| Effective Tax Rate | 21.04% |
Stock Price Statistics
The stock price has decreased by -0.78% in the last 52 weeks. The beta is 0.11, so TPEX:4105's price volatility has been lower than the market average.
| Beta (5Y) | 0.11 |
| 52-Week Price Change | -0.78% |
| 50-Day Moving Average | 76.18 |
| 200-Day Moving Average | 78.60 |
| Relative Strength Index (RSI) | 46.66 |
| Average Volume (20 Days) | 657,165 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:4105 had revenue of TWD 6.65 billion and earned 1.73 billion in profits. Earnings per share was 6.96.
| Revenue | 6.65B |
| Gross Profit | 3.83B |
| Operating Income | 1.86B |
| Pretax Income | 2.33B |
| Net Income | 1.73B |
| EBITDA | 2.06B |
| EBIT | 1.86B |
| Earnings Per Share (EPS) | 6.96 |
Balance Sheet
The company has 2.94 billion in cash and 2.11 billion in debt, with a net cash position of 832.99 million or 3.35 per share.
| Cash & Cash Equivalents | 2.94B |
| Total Debt | 2.11B |
| Net Cash | 832.99M |
| Net Cash Per Share | 3.35 |
| Equity (Book Value) | 7.75B |
| Book Value Per Share | 27.90 |
| Working Capital | 3.41B |
Cash Flow
In the last 12 months, operating cash flow was 1.96 billion and capital expenditures -127.67 million, giving a free cash flow of 1.84 billion.
| Operating Cash Flow | 1.96B |
| Capital Expenditures | -127.67M |
| Depreciation & Amortization | 198.80M |
| Net Borrowing | -159.13M |
| Free Cash Flow | 1.84B |
| FCF Per Share | 7.39 |
Margins
Gross margin is 57.57%, with operating and profit margins of 27.98% and 26.04%.
| Gross Margin | 57.57% |
| Operating Margin | 27.98% |
| Pretax Margin | 35.07% |
| Profit Margin | 26.04% |
| EBITDA Margin | 30.97% |
| EBIT Margin | 27.98% |
| FCF Margin | 27.61% |
Dividends & Yields
This stock pays an annual dividend of 4.50, which amounts to a dividend yield of 5.91%.
| Dividend Per Share | 4.50 |
| Dividend Yield | 5.91% |
| Dividend Growth (YoY) | 7.14% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 64.57% |
| Buyback Yield | 0.02% |
| Shareholder Yield | 5.93% |
| Earnings Yield | 9.12% |
| FCF Yield | 9.67% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 13, 2014. It was a forward split with a ratio of 1.067.
| Last Split Date | Aug 13, 2014 |
| Split Type | Forward |
| Split Ratio | 1.067 |
Scores
TPEX:4105 has an Altman Z-Score of 4.79 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.79 |
| Piotroski F-Score | 5 |